NCT00047203
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Refractory Multiple Myeloma
Explore clinical trials studying Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.
153 public trials
23 recruiting studies
Refractory Multiple Myeloma trial results
NCT00028821
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00003166
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
- Locations
-
- Case Western Reserve University Cleveland, Ohio, United States
NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Completed
Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
NCT00124605
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- City of Hope Duarte, California, United States
NCT00253578
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00306813
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Dept. of Internal Medicine II, University of Wuerzburg Würzburg, Bavaria, Germany
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States